// App-Quantinova.ai

: NMR-based metabolomics of exhaled breath condensate for assessing the effects of inhaled corticosteroids in COPD patients

Researchers

Presenter

  • Paolo Montuschi

Principal Investigators

  • Giuseppe Santini

  • Nadia Mores

  • Tim Higenbottam

  • Alessia Vignoli

  • Leonardo Tenori

  • Francesco Macagno

  • Claudio Luchinat

Medical Centers

  • Catholic University of the Sacred Heart, Department of Pharmacology, Rome, Italy

  • Pharmaceutical Medicine Royal College of Physicians, London, United Kingdom

  • University of Florence, Department Neurofarba, Florence, Italy

  • Catholic University of the Sacred Heart, Department of Cardiovascular Medicine, Rome, Italy

Locations

  • Italy

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • Prostaglandin E2

Drug/Treatment

  • Advair HFA

  • beclomethasone dipropionate/formoterol (NEXT DPI)

  • Fluticasone propionate

  • Fluticasone furoate

  • Beclomethasone dipropionate

  • Prostaglandin

  • Fluticasone

  • Formoterol

  • Salmeterol Xinafoate

  • Dinoprostone

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved